PENN HIGHLANDS ELK — History
CCN 391315 | 3-year financial timeline | COVID resilience: 48/100
🛡️ Public data only — no PHI permitted on this instance.
$67M
Latest Revenue (FY2022)
+2.6%
Revenue CAGR (3yr)
-0.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $64M | $68M | $67M | -0.4% | +2.6% |
| Operating Expenses | $63M | $65M | $68M | +4.7% | +4.1% |
| Operating Margin | 2.5% | 4.4% | -0.5% | -112.1% | +0.0% |
| Net Income | $2M | $3M | $-0M | -112.1% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 4,614 | 6,105 | 5,226 | -14.4% | +6.4% |
| Medicare Day % | 46% | 44% | 38% | -15.2% | -9.4% |
| Medicaid Day % | 13% | 12% | 11% | -14.5% | -10.0% |
COVID Impact & Recovery
Resilience Score: 48/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +5.2% ($64M → $67M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.6%
This Hospital
+7.6%
State Avg
Latest Margin
-0.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $69M | -2.0% |
| FY2024 (proj) | $71M | -3.5% |
| FY2025 (proj) | $72M | -5.0% |